Clinical Trials Logo

Clinical Trial Summary

An extension of the PREMOD2 trial, the PREMOD2 Follow-Up trial will evaluate the neurodevelopmental outcomes at 22-26 months corrected age of preterm children who received UCM or DCC. This prospective multi-national randomized controlled trial (RCT) is a two-arm parallel non-inferiority design of two alternative approaches of treatment.


Clinical Trial Description

The PREMOD2 Follow-up trial will examine the difference in early childhood neurodevelopmental outcomes of subjects enrolled in the PREMOD2 umbilical cord milking (UCM) vs. delayed cord clamping (DCC) trial, using standardized neurologic and developmental assessments at 22-26 months corrected age (CA). The corrected age may be extended out to 42 months CA due to Covid-19 pandemic for undetermined period of time. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03476980
Study type Interventional
Source Sharp HealthCare
Contact Anup Katheria, MD
Phone 858 939-4170
Email anup.katheria@sharp.com
Status Recruiting
Phase N/A
Start date July 6, 2019
Completion date December 2024

See also
  Status Clinical Trial Phase
Completed NCT04697147 - Zika and Neurodevelopment Among Infants in Grenada N/A
Completed NCT04888377 - ASPIRIN: Neurodevelopmental Follow-up Trial
Active, not recruiting NCT05504863 - RAPIDIRON Trial Follow-up Study: RAPIDIRON-KIDS Study
Completed NCT03718520 - The Influence of in Utero Cannabis Exposure on Neonatal Brain Morphology and Structural Connectivity
Completed NCT04607109 - Long-term Neurodevelopmental Disorders of Prematurely Born Children and Parental Experience
Completed NCT04118738 - International Cohort Study of Children Born to Women Infected With Zika Virus During Pregnancy
Completed NCT03621943 - Umbilical Cord Milking in Non-Vigorous Infants Developmental Followup (MINVIFU) N/A
Completed NCT04652063 - Osteopathic Manipulative Medicine to Reduce Developmental Delays N/A
Recruiting NCT05186155 - Analysis of Ocular and Neurodevelopmental Function for Retinopathy of Prematurity
Recruiting NCT05996211 - The Swiss Neurodevelopmental Outcome Registry for Children With CHD
Completed NCT05901623 - ASQ Scores of Transient Hypothyroxinemia of Prematurity
Enrolling by invitation NCT04529382 - Neurodevelopmental Outcome After Fetal Neonatal AlloImmune Thrombocytopenia
Recruiting NCT04347590 - Continuous Glucose Monitoring and Cerebral Oxygenation in Preterm Infants N/A
Active, not recruiting NCT03782610 - Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes